Health & Safety Issues in Orlando | Orlando Legal Examiner

Su ReNu Abogado

Si ud. ha estado usando la soluciÃ³n ReNu para sus lentes de contacto y ha experimentado una herida de los ojos, posiblemente podrÃa recibir compensaciÃ³n por su herida. Es muy importante que ud. consulte con un oftalmÃ³logo inmediatamente. El doctor tiene que tomar una muestra de sus ojos para det

By The Legal Examiner

/ 1 May 2006

Defibrillator Malfunctions on the Rise

According to a study published in The Journal of the American Medical Association, malfunctions in implantable cardioverter defibrillators, or ICDs, are on the rise. The device is designed to keep the heart pumping properly and efficiently. Between 1990 and 2002, a total of 2.25 million pacemakers a

By The Legal Examiner

/ 1 May 2006

Bausch & Lomb Notified by Hong Kong Officials in Fall 2005

According to an article published in the Wall St. Journal, the maker of ReNu contact lens solution, was notified of eye infections in November 2005. The number of those infected with the fungus fusarium keratitits has now risen from 176 last week to 186 cases in 29 states. The product distributed in

By The Legal Examiner

/ 28 Apr 2006

Bausch & Lomb Lawsuit Filing Today

This afternoon I’ll be filing a civil lawsuit against Bausch & Lomb, the manufacturer of ReNu contact lens solution. I’ll be filing in US District Court for the Middle District of Florida on behalf of a woman who has lost nearly 80% of her vision in her left eye. Unfortunately, she is not a surgical

By The Legal Examiner

/ 27 Apr 2006

FDA Experts' Conflicts of Interest

As a governmental oversight agency, it should be appalling that the FDA uses experts who have financial interests in the drugs and products about which they provide expert testimony. Yet, in a study conducted by the consumer group Public Citizen, that is exactly what is happening. How can any expert

By The Legal Examiner

/ 26 Apr 2006

Vioxx According to Jurors

There’s an insightful article in the online version of the Wall St. Journalregarding what jurors think when it comes to the pharmaceutical giant Merck and their drug Vioxx. The article states that three things are important when it comes to prevailing in a lawsuit against the maker of Vioxx: 1)show

By The Legal Examiner

/ 24 Apr 2006

Court Documents Show Ortho McNeil Knew Ortho Evra Was Lethal

Documents have surfaced in litigation that show Ortho-McNeil has been analyzing the FDA’s death and injury reports on women using the Ortho Evra birth-control patch, and has charts that show a higher rate of blood clots and deaths in women on the patch when compared to women who take birth-control p

By The Legal Examiner

/ 24 Apr 2006

GAO Criticizes FDA on How it Handles Drugs

The Government Accountability Office has published a report sharply critical of the Food and Drug Administration. The report states that the organization is sometimes too slow in recognizing safety problems once drugs have gone to market. The GAO report also says the FDA does not have clear policies

By The Legal Examiner

/ 24 Apr 2006

ReNu Being Removed From Shelves-What's Next?

As the Bausch & Lomb contact solution is being removed from store shelves all across the country, users of the ReNu with MoistureLoc can do several things: 1) they need to monitor the health of their eyes ie. beware of symptoms including blurry vision, pain or redness, excessive discharge and increa

By The Legal Examiner

/ 15 Apr 2006

Fosamax: An Example of What's Wrong with the Pharma Industry

When I discovered that Fosamax belonged to the same family of drugs as those employed in chemotherapy treatments and that these class of drugs were thought to cause osteonecrosis, I wanted to know why Merck hadn’t come forward with that knowledge. Well, as Merck has shown in its defense of Vioxx, th

By The Legal Examiner

/ 15 Apr 2006

Merck and Fosamax

It appears the manufacturer of Fosamax, the osteoporosis drug, knew about potential serious problems with the drug back in 2004. Fosamax belongs to a family of drugs called bisphosphonates which are believed to cause a severe osteonecrosis. Merck has made $3million from Fosamax and didn’t want to ch

By The Legal Examiner

/ 14 Apr 2006

Fosamax-Merck's Latest Headache

For Merck & Co. the bad news doesn’t seem to end. On the heels of being hit with $9 million in punitive damages from its drug Vioxx, Merck is now facing lawsuits from its osteoporosis drug Fosamax. Fosamax is a defective product because it can cause osteonecrosis of the jaw, or a rotting of the jaw

By The Legal Examiner

/ 13 Apr 2006